1+1.232x2-0.099x3+ 0.091x4-1.292x5-1.825x6-0.911x7, (2) where x1 is age in years; x2 is presence of cardiovascular disease: no - x2 = 0, yes - x2 = 1; x3 is systolic blood pressure in mmHg; x4 is diastolic blood pressure in mmHg; x5 is presence of POAG with relatives: no - x5 = 0, yes - x5= 1; x6 is presence of comorbidity eye: no - x6 = 0, yes - x6 = 1; x7 is genetic variant locus -308G/A TNFα: for option AA- x7 = 1 for variant AG- x7 = 2, for option GG- x7 = 3. If P is greater than 60 - predict risk of developing POAG with ineffective conservative therapy, if P is less than 40 - predict effectiveness of conservative treatment of POAG, if P is greater than 40 but less than 60 - more thorough dynamic follow up is necessary.;EFFECT: essence of method lies in that it includes isolation of DNA from peripheral venous blood.;1 cl, 2 dwg, 3 ex"/>
公开/公告号RU2592200C2
专利类型
公开/公告日2016-07-20
原文格式PDF
申请/专利号RU20140137727
发明设计人 OVCHAROVA VERONIKA SERGEEVNA;PROSHCHAEV KIRILL IVANOVICH;CHURNOSOV MIKHAIL IVANOVICH;TIKUNOVA EVGENIYA VIKTOROVNA;
申请日2014-09-18
分类号C12Q1/68;G01N33/49;
国家 RU
入库时间 2022-08-21 14:10:40